Post My Press Release

Free Press Release Distribution

Author: chaitanyag (Page 1 of 23)

Pneumonia Testing Market Size, Status and Forecast 2018-2026

The blood tests are used to confirm an infection and to try to identify the type of organism causing the infection, but however precise identification is not always possible through the blood tests. Further, the chest X-ray also helps the doctor to diagnose pneumonia and determine the extent and location of the infection. The chest X-ray can also detect the kind of germ is causing pneumonia. The pulse oximetry test is performed to measure the oxygen level in the blood, as Pneumonia can prevents lungs from moving enough oxygen into the bloodstream. Besides all these test the sputum test is used to analyses or pinpoint the cause of the infection with the sample of fluid from lungs, which is taken after deep cough.

Furthermore, if the pneumonia isn’t clearing as quickly as expected the doctors recommend a chest CT scan to obtain a more detailed image of the lungs. Moreover, if the patients shows serious symptoms or health conditions pleural fluid culture test is carried out where a fluid sample is taken by putting a needle between the ribs from the pleural area to analyze the type of infection.

Pneumonia Testing Market Dynamics

The recent advancements in pneumonia testing systems, such as the development of enhanced nucleic acid detection tests and advancement in POC tests is the major factor that contributes toward the growth of the pneumonia testing market size. As POC tests offers multiple benefits offered such as, ease of use, and rapid results. For instance, The urinary antigen is an extremely-effective rapid test that allows targeted therapy foe legionnaire at the point-of-care itself.

Further, increasing adoption of molecular diagnostic test in the developing economy is anticipated to provide lucrative opportunities to the pneumonia testing market. Due to increased application of biomarkers in molecular diagnostic, due to advantages of biomarkers such as aiding in early detection of specific diseases, supports the molecular diagnostics test for pneumonia testing market.

Initially, in the traditional method, cultures are used to detect pneumonia causative organisms. This is a time-consuming process with a higher error rate when compared to rapid diagnostics. In a few cases such as legionella, culture identification is not readily available and this increases the mortality rate of pneumonia cases caused by it.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1742

Pneumonia Testing Market – Regional Insights

North America accounted for the largest share in the pneumonia testing market, followed by Europe market in 2016. This is attributed to growing popularity for POC tests within the healthcare sector. Further, the ongoing research and development activities are also on rise for the development of more advanced PCR-based technologies, which could be used for faster results.

Further, pneumonia testing market in accounts second largest share in Europe region, primarily because of their robust, well-developed healthcare infrastructure and a greater awareness of a geriatric population likely to develop such health issues.

Furthermore, several pharmaceutical and biotechnological companies are focusing on expanding in Asia Pacific region, to maximize on their R&D efforts as the Asia Pacific region provides better access to patients for clinical trials, with lower cost operational efficiencies. Increasing government investment in research and development is also expected to foster growth of Pneumonia Testing in Asia Pacific region.

Pneumonia Testing Market – Competitive Analysis

Major players are focused on collaborations and mergers, to enter the pneumonia testing market. For instance, in April 2017, Abbott acquired Alere, which dominated POC testing for pneumonia testing market with its BinaxNOW Streptococcus pneumoniae antigen card for bacterial pneumonia and BinaxNOW RSV Card for viral pneumonia.

Key players operating in the market are Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.

Click To Reading More On Pneumonia Testing Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Hunter Syndrome Treatment Market Report Released Forecasting Movement in the Industry

Hunter syndrome also called as Mucopolysaccaridosis type II (MPS II), is the disorder affecting several parts of the body. Hunter syndrome is inherited genetic disorder caused by a malfunctioning or missing enzyme. At birth hunter syndrome individuals do not display any features of the disorder, amid ages 2 and 4, changes starts to show as large round cheeks, an enlarged tongue, full lips, and a broad nose. As the disorder advance’s, individuals need more medical assistance. According to the National Institute of Health 2018 report, Frequency of MPS II is 1 in 100,000 to 1 in 160,000 in males. Hunter syndrome is of two type, severe and mild. These both affect many different tissues and organs. Individuals suffering from severe type condition experience a decline in rapid intellectual function and disease progression. Individuals with the severe case begin to lose basic functional skills between at the ages of 6 and 8. The normal life expectancy of these people is 10 to 20 years. Individuals with mild type also have a shortened lifespan, they live into adulthood and their intelligence is not affected, major causes of death in these individuals is airway obstruction and heart disease. Several diagnostic tests are performed to diagnose hunter syndrome, which includes iduronate-2-sulfatase (I2S) enzyme activity test and a genetic testing. The urine test for GAGs is the most frequently used laboratory screening test for an MPS disorder. Advantages offered by this diagnosis test such as quick results and rapid diagnosis is driving growth of the hunter syndrome treatment market globally.

Hunter Syndrome Treatment Market – Dynamics

As Hunter syndrome has no permanent cure, the treatment mainly focuses on management of indications, signs, and difficulties associated with the disease advancement. Increasing number of population suffering from hunter syndrome has boosted the market growth for Hunter syndrome treatments.  For instance, in 2014, around 970 patients were enrolled in Hunter Outcome Survey (HOC) which increased to 1195 patients in 2017. Moreover, high burden of rare diseases, tax warier, fee reductions and grants, success for the drugs in pipeline with faster market access, financial incentives for orphan drug development to recover R&D costs, favorable regulations for orphan products development are some of the factors expected to fuel market growth over the forecast period. Rising attention of major biopharmaceutical companies on research and development of drugs for treatment of rare diseases is expected to boost demand for mucopolysaccharidosis treatment drugs. Moreover, the number of treatment options currently in pipeline is expected to boost the growth of market during the forecast period.

However, various issues limiting the market growth are heterogeneity of the disease, high cost of treatment, and lack of awareness are some the factors are restraining the growth of the market.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1749

Hunter Syndrome Treatment Market – Regional Insights

On the basis of region, the global blood stream infection testing market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America accounted for the largest market share in the global hunter syndrome treatment market due to favorable funding for research and development, better medical facilities, regulations for orphan products development, and rising awareness among the people regarding disrobers and disease. For instance, in 2017, Research funded by the National Institute of Neurological Disorders and Stroke (NINDS) has shown that viral-delivered gene therapy can stop the buildup materials stored in the brain cells and improve memory and learning. In the recent years, health insurance coverage and various reimbursement policies for such costly drugs also influencing pharmaceutical companies to invest in drug development. Moreover, Introduction of particular orphan drug regulations has allowed and increased research and development of various therapies for treatment of several such rare diseases. Developing healthcare infrastructure in Asia Pacific region is providing an opportunity for biopharmaceutical companies to penetrate in this region, which is fueling growth of the market.

Hunter Syndrome Treatment Market – Competitive Landscape

Key players operating in the global hunter syndrome treatment market include ArmaGen, Inc., BioMarin Pharmaceutical, Inc., Genzyme, Sangamo Therapeutics, a Sanofi Company, and others. Key players are engaged in developing new technologies and collaborations in order to retain dominant position in the market. For instance, in 2014, Shire Plc announced collaboration with ArmaGen to develop AGT-182 drug for treatment of hunter syndrome.

Click To Reading More On Hunter Syndrome Treatment Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Gastrointestinal Stents Market : Rise in Trend of Home Health Care is Anticipated to Drive the Growth

Stents are tubular device used for insertion in lumen such as esophagus, colon or blood vessel. Stents are safe and effective alternative to surgery or repetitive endoscopic procedures. Gastrointestinal stents are used to open bile ducts, esophagus, small bowel, and colon when blocked by large, cancerous tissue growth. Stents can be removable or permanently implantable based on the material used. The role of stenting is decreasing patients’ digestive tract obstruction. Moreover, advancement in technology has led to improvement in stent performance and reduced stent-induced complications to improve quality of life and this is expected to propel the gastrointestinal stent market growth.

Gastrointestinal Stents Market – Market Dynamics

Growth of the global gastrointestinal stents market is expected to be fuelled by increasing product launches with novel technology by key players in the market. For instance, in 2013, Cook Medical Inc. received U.S. Food and Drug Administration (FDA) for biliary stent, adding to the line of controlled-release gastrointestinal tract. Moreover, Evolution biliary stent incorporates patency design, to prevent migration of stent after its insertion. Furthermore, in 2012, Boston Scientific Corporation launched WallFlex, biliary Transhepatic Stent System for the treatment of benign biliary strictures. Companies are focusing on manufacturing stents with biodegradable material to eliminate stent removal procedures. However, implantable products are subjected to stringent regulations, and this is expected to hinder growth of the gastrointestinal stent market. Moreover, complication associated with gastrointestinal stent implantation is also expected to be major factor leading to low adoption of these device.

Increasing demand for minimally invasive procedures is expected to be a major factor driving growth of gastrointestinal stents market size. Gastrointestinal stenting is considered as minimally invasive therapy and is increasingly gaining popularity, owing to its advantages such as low risk of infection, less recovery time as compared to conventional open surgery procedures, and reduced hospital stay.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1756

Increasing prevalence of urological and gastrointestinal disorders are propelling demand of gastrointestinal stents during the forecast period. According to Center for Disease Control and Prevention (CDC), in 2015, number of adults diagnosed in U.S. with ulcer in digestive tract are 14.7 million, comprising 6% of the total adult population. Moreover, according to American Cancer Society’s estimation for year 2018 suggests that 9,220 new cases of colon cancer are expected to be diagnosed in the U.S. Moreover, increasing number of patients with gastrointestinal tumors is also adding to patient pool that can be subjected to gastrointestinal stent implantation.

Gastrointestinal Stents Market – Regional Analysis

Regional segmentation of Gastrointestinal Stents Market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held the dominant position in the gastrointestinal stents market in 2017 and is expected to retain its dominance over the forecast period. This is owing to increasing number of intestinal cancer cases and favorable reimbursement policies in the region. For instance, in 2017, American Cancer Society estimated 4,000 to 6,000 cases each year in the U.S. for gastrointestinal stromal tumors.

Gastrointestinal Stents Market – Competitive Analysis

Major market players operating in the gastrointestinal stents market are Boston Scientific Corporation, Medtronic plc, Olympus Medical System, Cook Medical, Ella-CS, Endo-Flex, Diagmed Healthcare, Micro-Tech, W. L. Gore & Associates and Taewoong Medical Co., Ltd.

Market players are focusing on inorganic strategies such as mergers, acquisitions, or collaborations to increase their foothold in the market. For instance, in May 2018, Olympus— a company that designs and delivers innovative solutions for medical and surgical procedures—entered into an agreement with M.I. Tech, a company that designs stents and other devices. Under this agreement, HANAROSTENT, biliary and esophagus stents rolled in the EndoTherapy product portfolio of the company. The displacement of the stents is a major issue faced after the stent is been placed. Targeting these issues, in 2017, W. L. Gore & Associates, the manufacturer of Gore Viabil short wire biliary endoprosthesis stent, launched anti-migration assurance program, under which device will be replaced within a period of one year if it migrates. Furthermore, in 2016, Boston Scientific launched AXIOS stent and Electrocautery Enhanced delivery system, endoscopic system used for minimally invasive treatment of pancreatitis, obtained as a part of acquisition of Xlumena. In 2015, Cardinal Health announced acquisition of Cordis, business of Johnson & Johnson, for US$ 1.944 Bn.

Click To Reading More On Gastrointestinal Stents Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Cervical Total Disc Replacement Device Market Overview and Share Forecasted to 2026

The global cervical total disc replacement market was valued at US$ 771.6 million in 2017, and is expected to witness a CAGR of 22.1% over the forecast period (2018 – 2026).

Increasing prevalence of cervical degenerative disc disorder is expected to propel growth of the total disc replacement devices market. According to an article ‘Global Burden of Disease’ published in the journal Lancet in 2016, neck pain is one of the most prevalent disease worldwide, which degrades the quality of life. Major cause for neck pain is chronic disease cervical degenerative disease. According to International Association for the Study of Pain factsheet in 2017, neck pain affects 30-50% general population annually, 15% of this population is projected to experience chronic neck pain in their lifetime. This neck pain is associated with cervical disc disorder. Increasing number of old age population worldwide is expected to fuel growth of total disc replacement devices market, owing high risk of developing degenerative disease related to cervical spine. Other treatment approaches such as pharmacological intervention do not provide long lasting cure therefore disc replacement remains key treatment approach.

However, high cost associated with artificial disc is expected to restrain growth of the market. Private insurer may not cover the cost of cervical total disc replacement device along with cost of surgery, therefore in this case patient has to do out of pocket expenditure for receiving device and surgery.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1763

Innovative products by key players to drive growth of the cervical total disc replacement devices market

Several companies are launching the new products with better clinical safety and efficacy, which is expected to fuel growth of C-TDR market. Manufacturers are introducing new products with varying material and design aiming to provide better relief and simulation with natural cervical disc. In February 2018, Simplify Medical received the U.S. patent for innovative cervical motion preservation intellectual property (IP) portfolio. The Simplify Disc from Simplify Medical is anatomically designed with low height implants option till four mm. Therefore, it minimizes risk associated with radiation, optimize long-term durability, simplify implantation, and increase access to cervical disc replacement for patients with smaller anatomies. It is made up of no-metallic PEEK material, which allows postoperative care without need of CT scan. Companies such as AxioMed are involved in geographic expansion of their innovative products. For instance, in 2016, AxioMed received approval for cervical and lumbar Freedom viscoelastic disc replacement devices from the Therapeutic Goods Administration (TGA) of Australia. First surgery that utilized artificial disc from AxioMed was carried out in 2017

Key players operating in the global cervical total disc replacement devices market include AxioMed Corporation, DePuy Synthes Spine, FH Orthopaedics, Globus Medical, LDR Holdings, Medicrea, Medtronic Sofamor Danek, NuVasive, Osimplant, Pioneer Surgical, Ranier Technology, Spinal Kinetics, Spinal Motion, and Stryker Corporation

Click To Reading More On Cervical Total Disc Replacement Device Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Sample Preparation Market: Moving Towards a Brighter Future

The global sample preparation market was valued at US$ 5.7 billion in 2017 and is expected to witness a CAGR of 6.3% over the forecast period (2017–2025).

Increasing interest in developing quick, cost-effective, and environmentally friendly sample preparation techniques, lead to develop new methods which will eventually minimize the extraction steps, reduce solvent consumption, and thereby automate the sample preparation system. Sample preparation is necessary to isolate the desired or targeted components from complex matrices, which most analytical instruments cannot handle the matrix directly. Sample preparation is a crucial process which can greatly impact the accuracy of research and are responsible for the success of downstream applications, such as nucleic acid or protein isolation and purification, pipetting, and other liquid-handling requirements. Current sample preparation trend includes miniaturization, automation, high-throughput performance, ability of new sample preparation instruments to combine with existing analytical instruments and reduction in solvent volume and time.

Moreover, continuous innovation in sample preparation and integration of new technology, will further drive the sample preparation market. For instance, integration of QuEChERS method in solid phase extraction allows simple and streamline sample preparation system for analysis of various pharmaceutical and veterinary drugs. Automated sample preparation eliminates human error, low sample purity, and sample contamination, allowing consistent result at every time.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/1594

Increasing adoption of innovative technologies and high requirement for product development are propelling demand for automation in sample preparation instrument. Furthermore, automated sample preparation offer various advantages such high productivity, repeatability, and traceability. Also, it lowers operator’s health and safety risks by reducing exposition to hazardous chemicals and biological laboratory samples. Furthermore, customers prefer total framework solutions, instead of standalone workstations, as it offers integration of different sample preparation instruments at one place. Automated sample preparation enhances the productivity of laboratory by minimizing the resource allocation for repetitive tasks such as sample extraction, filtration, weighing, dilution, and sample analysis.

Moreover, key players are focused on introducing innovative products in the sample preparation market, which is expected to drive growth of the market. For instance, in March 2018, Inlabtec AG, introduced TA12 Serial Diluter: a low cost, high productivity dilation system for quantifying live probiotic bacteria. Moreover, in February 2018, Teledyne CETAC Technologies launched SimPrep: a new automated sample preparation system. The new system offer wide range of syringes from 20 microliter to 50 milliliter and it combines multiple techniques such as Inductively Coupled Plasma Mass Spectrometry (ICP-MS), atomic absorption (AA), colorimeter and Flow Injection Analysis (FIA).

Rapid Advancement in Blood Collection Tools and Growing Research and Development Funding from Various Government and Private Organizations are Driving Growth of the Global Sample Preparation Market

Various government and private organizations are focusing on increasing R&D investment in clinical diagnostic, forensic, proteomics, and genomics research. Proper sample preparation is vital to obtain significant and accurate results. Moreover, increasing research and development (R&D) spending by various government and private organizations is expected to increase adoption of advanced sample preparation instrument in near future. For instance, The German Research Foundation (DFG) on March 2018, funded US$ 17.3 million to four new German sequencing centers. The funding will be used to conduct research in next-generation sequencing field. In April 2018, DNA Script received US$ 5.5 million in funding from European Commission and French investment bank: Bpifrance. Funding is provided as a part of subsidies and refundable advances of European Commission’s Horizon 2020 European Innovation Council program and Bpifrance’s innovation development programs. DNA Script intends to make innovation in synthesis of DNA and RNA using its proprietary enzymatic technology.

Emerging markets such as Asia Pacific, Latin America, Middle East and Africa with their increasing population, high healthcare expenditure and their ability to file increasing numbers of patents in different research fields, will lead to drive sample preparation market, in these region. For instance, according to the World Intellectual Property Indicators 2017 report, Asia (64.6%) accounted to register highest percentage of patent applications for 2016, followed by North America (20.5%), Europe (11.3%), Latin America and the Caribbean (2%), Oceania (1.1%), and Africa (0.5%). According to the same source, in 2016, China registered highest number of patents (1,338,503 patent applications), with 21.5% annual growth.

Click To Reading More On Sample Preparation Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Cellulite Treatment Market by Manufacturers, Regions, Forecast to 2026

Cellulite is a condition in which a person’s skin of their thighs, buttocks, and hips appears dimpled. Common names for cellulite include cottage cheese skin, orange-peel skin, hail damage, and the mattress phenomenon. This condition is commonly observed in women than in men due to the fat deposition in a normal women represents between 18% and 20% of body weight, whereas in men it represents only 10% to 15%. According to 2015, article published by American Journal of Clinical Dermatology, around 80 and 90 percent of women are affected by cellulite at some point in their lives. Appearance of lumpiness beneath the skin due to fat deposits distorts and pushes the connective tissues, thus leads to the characteristic of cotton cheese appearance of the skin. Causes of cellulite are unidentified, however it seems to result from an interface between the fat layer and connective tissue in the dermatological layer, which is below the surface of the skin. Hormones such as noradrenaline, insulin, estrogen, prolactin, thyroid hormones play a significant role in cellulite development. Moreover, other factors such as genetics, age, diet, and lifestyle also affect cellulite development. Cellulite treatment market is significantly gaining traction due to increasing prevalence of obesity.

Cellulite Treatment Market – Dynamics

One of the major drivers propelling growth of the cellulite treatment market is the growing obese population. For instance, according to 2014 National Institute of Diabetes and Digestives and Kidney Diseases report, 2 in 3 adults (70.2 percent) were diagnosed with obesity in the U.S. Moreover, advancements in technology such as Cellulaze™ the world’s first and only minimally invasive medical device designed to eliminate cellulite which uses SideLight 3D side-firing technology to target the causes of cellulite beneath the skin, are boosting the growth of the cellulite treatment market size. For instance, according to 2017, American Society of Plastic Surgeons report, around 1.8 million cosmetic surgical procedures were performed in 2017. Growing inclination towards achieving a slim body, lighter complexion, and better skin is also boosting demand for cosmetic treatment for cellulite. Furthermore, various technological advancement such as user-friendly pen shaped portable laser medical devices, is expected to boost growth of the market.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1773

Cellulite Treatment Market – Regional Insights

On the basis of the region, the global cellulite treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global market, owing to adoption of the innovative medical products and treatments, For instance, in 2015, The Food and Drug Administration (FDA) approved Cellina, a non-invaise cellulite treatment. Moreover U.S is observing fast increase in aging population, is expected to create robust demand for aesthetic repair market services in the country. For instance, According to the American Society for Aesthetic Plastic Surgery (ASAPS) 2016 report, it was estimated that over 11 million aesthetic procedures were performed by board?certified specialists, of which 16.5% were surgical procedures and 83.5% were non?surgical procedures.

Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to growing obese population in this region and increasing disposable income among the populace in the region.  According to 2017 Asian Development Bank Institute report Asia and the Pacific region is home to the largest absolute number of overweight and obese people, equivalent to about 1 billion.

Cellulite Treatment Market – Competitive Insights

Key players operating in the global cellulite treatment market include Tanceuticals, LLC., Nubway, Merz Pharma GmbH & Co. KGaA, Zimmer Aesthetics, Cymedics, Cynosure, Inc., Inceler Medikal Co. Ltd., and Syneron Medical Inc. Market players are focused towards collaborations and providing technologically advanced products to sustain their presence in the market.

Click To Reading More On Cellulite Treatment Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Digital Fluoroscopy System Market 2019 Future Insights and Forecast 2026

Digital fluoroscopy is form of X-ray that enables technician to visualize deep structures of the body. Digital fluoroscopy provides detailed images of different organs such as intestine, cardiac muscle, bladder, and stomach. Conventional X-ray records images to a film, while digital fluoroscopy helps in recording a series of images to the computer. Digital fluoroscopy is majorly used to check and evaluate the gastrointestinal tract, which includes stomach, esophagus, duodenum and the colon. Furthermore, it is used to diagnose tumors, ulcers, hiatal hernias, scarring, reflux, inflammation, and blockages. It examines and evaluates kidney function in venography and angiography procedures (placement of tubes in veins and arteries) and pain management procedures (nerve root blocks). Procedures that use fluoroscopy are orthopedic surgery, podiatric surgery, angiography, placement of Peripherally Inserted Central Catheter (PICC), placement of weighted feeding tube in the duodenum, urological surgery, cardiology, discography, lumbar puncture, and modified barium swallow study.

Digital Fluoroscopy System Market Dynamics:-

Increasing number of orthopedic surgeries and angiography are major drivers for growth of global digital fluoroscopy system market. According to a survey conducted by American Academy of orthopedic surgeons, in 2014, more than six million patients were reported for knee replacement surgeries, more than three million patients were reported for hip replacement surgeries and more than four million patients were reported for spinal fusion surgeries. Moreover, innovation in fluoroscopy devices is expected to fuel digital fluoroscopy system market growth. For instance, in 2015, Care Stream Health Corporation launched Carestream DRX Excel and Carestream DRX Excel Plus, this devices enhance workflow using fluoroscopy. These devices records both fluoroscopy and radiography sequences. Approvals of new products by regulatory bodies are also driving growth of the digital fluoroscopy system market size. For instance, in April 2018, Afga Healthcare received Food and Drug Administration (FDA) approval for DR multipurpose imaging system. It is a solution for digital radiography, digital fluoroscopy, and advanced clinical applications such as use of image processing software ‘DYNAMIC MUSICA’ for both static and dynamic (moving) images.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1782

Furthermore, mergers and acquisitions by key players are boosting growth of the digital fluoroscopy system market. For instance, in 2016, Canon Inc. acquired Toshiba’s Medical Equipment Unit. Canon is focused on developing new medical imaging, digital radiography, and fluoroscopy solutions along with Health IT software solutions.

High cost of devices and novel procedures in pipeline, which may provide better result than fluoroscopy are restraining growth of the digital fluoroscopy system market. For instance, endoscopic retrograde cholangioscopy procedure using spy glass rather than digital fluoroscopy to detect bile duct stones has completed phase three clinical trials in 2017, this is sponsored by Boston Scientific Corporation, a leading medical device company.

Digital Fluoroscopy System Market Regional Analysis:-

North America is expected to lead digital fluoroscopy system market due to high prevalence of medical conditions such as varicose veins, pulmonary embolism, peripheral artery disease, and pulmonary embolism. According to a study conducted by Center for Disease Control and Prevention (CDC), in 2016, more than 8.5 million people in U.S. are suffering from peripheral artery disease, out of which more than 12% are geriatric population. According to a survey conducted by National Institute of Health (NIH), in 2016, more than 40 million people in the U.S. are diagnosed with varicose veins. Such high prevalence of diseases can drive growth of the North America digital fluoroscopy system market as digital fluoroscopy system is used for diagnosis of these diseases.

Europe digital fluoroscopy system market is expected to witness significant growth due to launch of innovative digital fluoroscopy systems. For instance, in 2015, Koninklijke Philips N.V. launched ProxiDiagnost N90 DRF system. This device is a two in one digital radiography and fluoroscopy system, which provides high quality images with fast supporting workflow and increases room utilization. This system also gives high patient accessibility i.e. the system has small footprint area, open overhead table and area this enables technicians and caregivers to be close to the patient during the procedures causing no hindrance.

Moreover, Asia Pacific digital fluoroscopy system market is expected to grow at significant rate due to advancement in digital fluoroscopy equipment i.e. C arms and innovation in technology of digital fluoroscopy systems. For instance, in 2016, Toshiba Corporation launched Infinix-i sky and double sliding C arm. This device helps C arms to be positioned in many ways to perform all procedures with ease. It helps the clinicians increase their speed, coverage, and patient access.

Digital Fluoroscopy System Market Key Players:-

Key players operating in global digital fluoroscopy system market include Philips Healthcare, GE Healthcare, Siemens Health, Toshiba Medical Systems, Shimadzu Medical, Ziehm Imaging, Hitachi Medical Systems, Orthoscan Inc. and Hologic Corporation.

Click To Reading More On Digital Fluoroscopy System Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

Clinical Trial Supply and Logistics Market Insights, Share, Opportunity Analysis, Forecast Till 2026

The global clinical trial supply and logistics market size was valued at US$ 14.95 Bn in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026). 

Quantity of ancillary supplies and diverse vendors to produce those supplies have significantly increased in the market, owing to rising demand for developing and producing clinical supplies from end user manufacturers or investigators for global studies in a cost-efficient manner. According to an article published in the Applied Clinical Trials website, 2016, there are around 40,000 unique investigators worldwide conducting at least one FDA-regulated clinical trial. Furthermore, increasing prevalence of cancer across the globe is providing new opportunities for global biopharmaceutical research community, and clinical trial supply and logistics management to bring the respective drug to the market sooner by navigating the complex clinical & regulatory environment. According to the World Health Organization (WHO), there were around 555,318 new cases of cancer in 2012 in the Middle East. The region is expected to witness around 961,098 cases by 2030, which will be the highest number of cancer cases among other regions in the world.

Change in regulations related to clinical trials is also expected to have some impact on the market. In 2013, the European Union enacted good distribution practices (GDPs), which are now becoming a globally adopted guidance. Although the timeline is still under discussion, new regulations for clinical trials that are conducted in the European Union will be revealed in 2019. The new regulations could potentially impact the supply chain, although it is primarily geared to existing good manufacturing practices (GMPs) for products covered by an existing directive.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1798

Biologics are also expected to witness steady growth, owing to increasing research activities such as development of nanoparticle-based drug delivery systems in the field of genetics and biotechnology. For instance, in May 2018, Catalent Pharma Solutions collaborated with Valerius Biopharma AG, a Swiss biopharmaceutical company, for the development and manufacturing of Valerius’ biosimilar products, as alternatives to high-priced biologics. This is expected to boost clinical trial supply and logistics market growth over the forecast period.

Clinical Trial Supply and Logistics Market Regional Outlook

On the basis of region, the global clinical trial supply and logistics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold a dominant position in this market, owing to the adoption of technologically advanced products, well established regulatory agencies, and presence of major Contract Research Organizations (CRO’s) and biopharmaceutical company’s hubs. Moreover, factors such as improved healthcare facilities and better reimbursement scenario are also driving growth of clinical trial supply and logistics market in this region. The number of new vendors trying to enter the healthcare industry are expected to increase over the forecast period, as there are many niche market players trying to leverage the market share through new inventories in medical devices and drugs. Also, they will require clinical trial supply management to cut down costs across all aspects of the business, by reducing internal capacity – in terms of site maintenance and employee headcount. Thus, emerging economies such as Asia Pacific and Latin America has huge potential for market growth, and is projected to be the fastest growing region over the forecast period.

Click To Reading More On Clinical Trial Supply and Logistics Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Page 1 of 23

Powered by WordPress & Theme by Anders Norén